MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.

Prins TJ, Lai TJ, Li T, Fisher A, Eldred BSC, Mostafavi R, Liau LM, Chong RA, Nghiemphu PL, Cloughesy TF, Nathanson DA, Lai A.

Open source

DOI: 10.1007/s11060-026-05500-y
Published: 2026-03-12
Container: J Neurooncol
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11060-026-05500-y,
  title = {MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.},
  author = {Prins TJ and  Lai TJ and  Li T and  Fisher A and  Eldred BSC and  Mostafavi R and  Liau LM and  Chong RA and  Nghiemphu PL and  Cloughesy TF and  Nathanson DA and  Lai A.},
  year = {2026},
  journal = {J Neurooncol},
  doi = {10.1007/s11060-026-05500-y},
  url = {https://doi.org/10.1007/s11060-026-05500-y}
}

RIS

TY  - JOUR
TI  - MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.
AU  - Prins TJ
AU  -  Lai TJ
AU  -  Li T
AU  -  Fisher A
AU  -  Eldred BSC
AU  -  Mostafavi R
AU  -  Liau LM
AU  -  Chong RA
AU  -  Nghiemphu PL
AU  -  Cloughesy TF
AU  -  Nathanson DA
AU  -  Lai A.
PY  - 2026
JO  - J Neurooncol
DO  - 10.1007/s11060-026-05500-y
UR  - https://doi.org/10.1007/s11060-026-05500-y
ER  -

APA

TJ, P., TJ, L., T, L., A, F., BSC, E., R, M., LM, L., RA, C., PL, N., TF, C., DA, N., & A., L. (2026). MGMT downregulation by CRISPR/Cas13 RNA-guided RNA targeting enhances glioma cell sensitivity to TMZ chemotherapy.. J Neurooncol. https://doi.org/10.1007/s11060-026-05500-y

Source records

europe-pmc · retrieved 2026-09-26T20:07:27.091Z